Laurion Capital Management’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Laurion Capital Management’s Portfolio SYNH Stock Details SYNH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-22,220	Closed	-$1.29M	–	1222
2020 Q2	$1.29M	Buy	+22,220	New	+$1.19M	0.01%	374
2019 Q1	–	Sell	-9,708	Closed	-$382K	–	1396
2018 Q4	$382K	Buy	+9,708	New	+$451K	0.01%	749
2017 Q3	–	Sell	-10,900	Closed	-$638K	–	1959
2017 Q2	$638K	Sell	10,900 -100	-0.9%	-$5.2K	﹤0.01%	1175
2017 Q1	$504K	Buy	+11,000	New	+$547K	﹤0.01%	911

Other funds holding SYNH

Advent International Boston, Massachusetts $4.24B AUM 4.24% 1-Year Est. Return

THLTP

Thomas H. Lee (THL) Partners Boston, Massachusetts $205M AUM 1.84% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return

Laurion Capital Management's SYNH Position: Q3 2020 in Review

Laurion Capital Management sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2020, closing a stake of 22,220 shares — an estimated $1.29M sold.

Laurion Capital Management first reported a position in SYNH in Q1 2017 and held it in 4 quarters. The position peaked at $1.29M in Q2 2020. 300 funds tracked by Wall St. Rank hold SYNH as of Q3 2020.

Laurion Capital Management reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2020 after selling out during the quarter.
Laurion Capital Management sold 22,220 Syneos Health, Inc. Class A Common Stock shares in Q3 2020, an estimated $1.29M.
Laurion Capital Management first reported a position in Syneos Health, Inc. Class A Common Stock in Q1 2017 and held it in 4 quarters.
Laurion Capital Management's Syneos Health, Inc. Class A Common Stock position peaked at $1.29M in Q2 2020.
300 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2020.

Based on Laurion Capital Management's 13F filing for Q3 2020, filed 13 Nov 2020.